Events & Webinars
Explore ASPI’s current event listings, including upcoming monthly webinars and educational sessions on Active Surveillance and related topics.
See the individual event page for timing, speaker information, and registration details. Looking for earlier ASPI sessions and archived recordings? Browse the past sessions below, or visit the ASPI meeting video archive.
Featured Event
Speakers: Joe Jones, Wayne Zimmermann, Mike Ondra, Dr. Ming Zhou, and Dr. Kevin Shee
Choosing Active Surveillance can be one of the biggest decisions a man makes after a prostate cancer diagnosis. But there can be another difficult question later on: How do you know when staying on Active Surveillance still makes sense — and when it may be time to consider treatment? For…
Archive
Speakers: Dr. Neal Shore, Dr. Channing Paller, and Dr. Neil Perlman
It’s time to spit for science and undergo germline genetic testing to see whether we carry mutations inherited from our parents that have a potential impact on the course of Active Surveillance for low-risk…
Speakers: Dr. Cathryn J. Lapedis, MD, MPH
Most patients have a hard time deciphering pathology reports they get after prostate biopsies. At the same time, many are puzzled with their Gleason score. Cathryn J. Lapedis, MD, MPH, a Clinical Assistant Professor…
The debate over transperineal vs. transrectal biopsies continues. There have been four randomized trials in the past year alone with somewhat contradictory results. Active Surveillance Patients International’s monthly webinar will be focused on these…
Speakers: Dr. Darryl Leong
Dr. Darryl Leong, an onco-cardiologist and Director at McMaster University and Hamilton Health Sciences Cardio-Oncology Program in Hamilton, Ontario, Canada will lay out the data along with strategies for improving heart health along with…
PSAs, MRIs and biopsies each tell part of the story of prostate cancer. But increasingly, biomarkers are playing a role in making decisions on Active Surveillance vs. treatment for men with prostate cancer. Active…
Kevin Ginsburg, MD, urologic oncologist at the Karmanos Cancer Institute/Wayne State University in Detroit, will be presenting a webinar for Active Surveillance Patients International (ASPI) entitled “Is favorable intermediate-risk PCa the future of AS?"
Can prostate cancers be seen by pathologists in biopsies but invisible on MRIs? Yes they can, and what does it mean? Dr, Mark Emberton, Professor of Interventional oncology at University College London and Dean…
Speakers: Mike Scott; Dr. Shee
Without clinical trials, such as ProtecT, patients with lower-risk prostate cancer would have had no choice other than aggressive treatment with risks of side effects impacting their quality of life. Active Surveillance Patients International (ASPI) is holding a webinar at 12:00PM ET Saturday, November 30, entitled “Your role in clinical research on early-stage prostate cancer.”
Speakers: Professor Freddie Hamdy; Professor Jenny Donovan
Active Surveillance Patients International will host it’s October meeting with guest speakers Professor Freddie Hamdy of Oxford University and Professor Jenny Donovan of the University of Bristol in England, who led this long, difficult, and game-changing study.
Peter Carroll, MD, MPH, of the University of California, San Francisco, one of the pioneers of Active Surveillance for low-risk prostate cancer, in the lat 1990s, will be speaking to Active Surveillance Patients International at noon Eastern on Sept. 28, 2024.
Speakers: Meghan Tierney; Mia Li-Burton
Active Surveillance Patients International (ASP) is presently a webinar at 12-1:30 p.m. Saturday, August 24 entitled "Evolution of Active Surveillance."
A diagnosis with prostate cancer isn't always a slam-dunk. Should you consider expert second opinions on your pathology and even MRIs before being rushed into aggressive treatment for prostate cancer? About 25% of biopsies…
